MedPath

Quallent Pharmaceuticals Health LLC

🇰🇾Cayman Islands
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

49

FDA:49

Drug Approvals

Adalimumab-ryvk

Approval Date
Feb 28, 2025
FDA

Levetiracetam

Approval Date
Mar 30, 2024
FDA

FINGOLIMOD

Approval Date
Mar 28, 2024
FDA

ezetimibe

Approval Date
Mar 20, 2024
FDA

Finasteride

Approval Date
Feb 28, 2024
FDA

Gabapentin

Approval Date
Jan 9, 2024
FDA

Hydroxychloroquine sulfate

Approval Date
Dec 21, 2023
FDA

Carvedilol

Approval Date
Dec 18, 2023
FDA

Sildenafil

Approval Date
Nov 30, 2023
FDA

escitalopram oxalate

Approval Date
Nov 22, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy